Jensen Huang: Wall Street Is Dead WRONG - These 3 Stocks Are Perfect Bargain Hunt Before November
3 extracted signals · 0 resolved · 3 still active
Millionaires Investment SecretsIndependent analyst profile- Source published
- 23 Oct 2026, 17:30 UTC
- Recorded by Tahlil Plus
- 23 Oct 2026, 20:30 UTC
AI-generated source summary
The video discusses the current market conditions for several tech and infrastructure companies, suggesting that the recent sell-off is overdone and presents an opportunity. For Coreweave (CRWV), the analysis highlights strong demand for compute power, with the company's stock trading at a discount. A target of $175 is inferred, with a fail bound set at $150. For Nebius (NBIS), the report notes impressive revenue growth and a strong balance sheet, suggesting a target of $200 with a fail bound at $140. Finally, Core Scientific (CORZ) is presented as oversold, with its stock price plummeting. The analysis infers a target of $20, with a fail bound at $10, based on its strategic infrastructure assets and positioning in the AI boom. The overall thesis is that these companies, despite current market headwinds, are fundamentally strong and poised for a significant recovery.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
3 signals remain active.
Millionaires Investment Secrets
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.